Journal of Bioequivalence & Bioavailability

International Conference & Exhibition Bioequivalence and Bioavailability

March 01-03,2010

Scientific Tracks Abstracts

• RECENT ADVANCES IN THE EVALUATION OF BIOEQUIVALENCE

  Sam H. Haidar

  PDF HTML

• BIOEQUIVALENCE TESTINGINDUSTRY PERSPECTIVE

  A.T. Bapuji

  PDF HTML

• CURRENT STRATEGIES FOR THE BIOEQUIVALENCE ASSESSMENT OF TOPICAL DERMATOLOGICAL DOSAGE FORMS

  Isadore (Izzy) Kanfer

  PDF HTML

• A QUICK ASSAY OF PATHOGENIC BACTERIA IN KIDNEY INFECTION USING GOLD NANO-BIOSENSORS

  Subhash C. Basu, Sara Seggerson, Kunal Saxena, Rocio del A. Cordona, Clare Lefave , Manju Basu, Juan Jiang , Albert Miller

  PDF HTML

• CHALLENGES IN CONDUCTING BA/BE ASSESSMENTS DURING CLINICAL DEVELOPMENT OF ONCOLOGY DRUGS

  Rajendra S. Pradhan

  PDF HTML

• EVALUATING EFFECT OF SELF-MICROEMULSIFYING DRUG DELIVERY FORMULATION AND CONCOMITANT ADMINISTRATION OF PIPERINE ON BIOAVAILABILITY OF SULPIRIDE, A P-GP SUBSTRATE AND BCS CLASS IV DRUG

  Kok-Khiang Peh, Mallikarjun Chitneni, Yusrida Darwis

  PDF HTML

• IN-VITRO AND INVIVO EVALUATION OF MICROPROCESSOR CONTROLLED IONTOPHORETIC TRANSDERMAL DRUG DELIVERY OF ANTI-CANCER DRUGS

  Chandrashekar.N.S

  PDF HTML

• BIOEQUIVALENCE IN TRANS DERMALS

  Charu Gautam

  PDF HTML

• EFFECT OF REPLICATE DESIGN ON DRUG VARIABILITY AND BIOEQUIVALENCE IN HUMANS

  Naji M. Najib, Isam Salem, Nasir M. Idkaidek

  PDF HTML

• EFFECT OF TRUNCATED AUC METHOD ON DRUG BIOEQUIVALENCE IN HUMANS: AN EMEA DRAFT GUIDELINE EVALUATION

  Naji M. Najib, Isam Salem, Nasir M. Idkaidek

  PDF HTML

• BIOEQUIVALENCE STUDY OF TWO FDC FORMULATIONS CONTAINING METFORMIN, GLIBENCLAMIDE AND PIOGLITAZONE IN HEALTHY INDIAN VOLUNTEERS

  U. S. Chakrabarty, A. K. Sarkar, Prof. (Dr.) Tapan Kumar Pal

  PDF HTML

• INTER-INDIVIDUAL VARIABILITY AND DRUG DEVELOPMENT: BA/BE AS RESEARCH TOOL

  Harish Padh

  PDF HTML

• BIOAVAILABILITY ENHANCEMENT OF ROPINIROLE BY USING NANOEMULSION BASED SYSTEM

  Dr Sushama Talegaonkar

  PDF HTML

• THE IMPORTANCE OF THE HUMAN PLACENTA EX VIVO PERFUSION MODEL IN THE DRUG DEVELOPMENT FOR HUMAN PREGNANCY

  Antoine Malek

  PDF HTML

• Enhancement of oral bioavailability of insulin in humans

  Adnan Badwan, Mayas Remawi, Nidal Qinna, Amani Mirghani, Tawfiq Arafat, Munther Melhim, Nasir M. Idkaidek

  HTML

• Biosimilar products selection: challenges for clinicians

  Khalid M Alkharfy

  PDF HTML

• Drug delivery in pregnancy: transport of nanoparticles across the human placenta and the fetal exposure

  Antoine Malek

  PDF HTML

• European regulations in the context of biosimilars

  Dr. Jean Louis Prugnaud

  PDF HTML

• Biosimilars and EU CHMP scientific advice

  Efthymios Manolis

  PDF HTML

• Biosimilar of epoetin alfa: issues on comparability and immumogenicity

  Lucia Del Vecchio

  PDF HTML

• In-silico selection of natural antileukaemia compounds

  Hany A. El-Shemy

  PDF HTML

• IN SILICO ADME PREDICTION USING QSPR STUDIES

  Dr Yash Paul Singla

  PDF HTML

• Bioequivalence Methods for Assessment of Highly Variable Drug - ABE, SABE, PBE and IBE

  Kwang-il Kwon, In-hwan Baek

  PDF HTML

• The application of bayesian/ frequentist analysis in bioequivalence/ bioavailability studies

  Ying Grace Li, Haoda Fu, David Manner, Lan Ni

  PDF HTML

• Sparse sampling strategies in pharmacokinetics and bioequivalence

  Shubha Rani

  HTML

• Average, individual and population bioequivalence - understanding the true variability of a product

  Bhaswat S. Chakraborty

  PDF HTML

• Bioavailability of flavonoids: in vitro methods for assessing bilitranslocasemediated membrane transport

  Sabina Passamonti, Lovro Ziberna, Federica Tramer

  PDF HTML

• Quantitation of Alpha Amyrin in Scoparia dulcis L. Whole Plant Extract by High Performance Liquid Chromatography

  Lakshmu Naidu. P. V, Kishore Kumar. K, Sujatha. S, Narasimha Rao. M

  PDF HTML

• Application of dermal microdialysis for the determination of bioavailability/ bioequivalence of topical drug products not intended for systemic circulation

  Isadore (Izzy) Kanfer

  PDF HTML

• ROLE OF Lipid based drug delivery systems in bioavailability enhancement

  Dr. Praveen S. Hiremath

  PDF HTML

• Scientific and regulatory challenges of bioavailability/ bioequivalence in the 21st century

  Dr. Mansoor A. Khan

  PDF HTML

• Bioavailability and Bioequivalence of Novel Drug delivery systems

  Dr. N. Udupa

  PDF HTML

• Nanosuspensions for improved drug bioavailability and targeted drug delivery

  Kamalinder. K. Singh

  PDF HTML

• Enhancing oral bioavailability of drugs using cyclodextrins

  B. S. Kuchekar

  PDF HTML

• Bioanalytical method transfer: challenges and recent developments

  Yarramraju Sitaramaraju

  HTML

• Bioanalytical method development of the metabolite 3-desmethylthiocolchicine in human plasma by LC-MS/MS

  Dr. Sangita Agarwal

  PDF HTML

• Protection against Seasonal and Avian Influenza Virus Infections Using Nucleic Acid-Based Antiviral Agents

  Jonathan P. Wong, Mary E. Christopher, Satya Viswanathan, Xiaojiang Dai, Glen Schnell

  PDF HTML

• Biochemical and Biological studies on Salt Stressed Spirulina platensis

  Emad A. Shalaby, Sanaa M. M. Shanab

  PDF HTML

• Standardization of herbal drug preparations using LC-MS

  Dr. Jawahar Lal

  PDF HTML

• Codeine and breastfeeding, what are the latest data in pharmacovigilance and EMEA regulation

  Dr. Raphael Serreau

  PDF HTML

• Clinical Study of the Bioequivalence of Trimetazidine Immediate Release and Modified Release Tablets

  Latif Ozbay, Durisehvar Unal, Dilek Erol

  PDF HTML

• Signaling Mechanisms of Endogenous Anticancer Molecules Derived From Extra Cellular Matrix Type IV Collagen

  Dr. Sudhakar Akulapalli

  PDF HTML

• Expanding applications for use of biologically modified nanoparticles in cancer research

  Dr. Eric Michael, Bratsolias Brown

  PDF HTML

• Imatinib resistance in chronic myeloid leukemia: role of COX-2, MDR-1 and HDACs

  Pallu Reddanna

  PDF HTML

• Phosphorylation of eIF2a-mediated signalling pathways in cell survival and suicide

  Kolluru V A Ramaiah

  HTML

• Differential regulation of HIF-1a under normoxic and hypoxic conditions

  Surya S. Singh, Rajesh M, Nalini J

  PDF HTML

• Design of new drug molecules to be used in reversing multidrug resistance in cancer cells

  Dr. Y.C. Mayur

  PDF HTML

• PK-PD integration / modeling of NSAID in veterinary pharmacology

  Mario Giorgi

  PDF HTML

• Regulatory requirements for orphan drugs delivery

  Basavaraj K. Nanjwade

  PDF HTML

• Assuring bioequivalence: pilot studies or dissolution?

  Ranjani Nellore

  PDF HTML

• Challenges for preparation of module 2 & 5 for BA/ BE for US & EMEA

  Neerja S

  PDF HTML

• What should be Indian pharma R&D's focus areas in 2010

  Pralhad Tayade

  PDF HTML

• In-Vitro Release and Pharmacokinetics of Anti-tubercle drug Ethionamide in Healthy male Subjects

  Mahmood Ahmad, Asad Ullah Madni, Muhammad usman

  PDF HTML

• Biomarkers in neurotoxicity

  Dr. Sadhana Sathaye

  PDF HTML

• Effect of antioxidants on polychlorinated biphenyls (PCBs) induced changes in male reproduction

  Dr.J. Arunakaran

  HTML

• Composite ion exchange materials and their applications to remove toxic metal ions

  Dr. Mu. Naushad

  PDF HTML

• Kidney, the major organ in the body to evaluate toxic and transport properties of environmental chemicals

  Sivakumar Gowder

  PDF HTML

• Cigarette smoke inhalation study for lung tumorigenicity in A/J mice

  R. B. Lichtner, B. Friedrichs, A. Buettner, F. Van Overveld, W. Stinn

  PDF HTML

• The proteome of the outer membrane vesicles of an antarctic bacterium pseudomonas syringae

  M V Jagannadham, Heramb M Kulkarni, C S Sundaram, V M Dhople

  PDF HTML

• Challenges in siRNA/ shRNA delivery and development of RNAi therapeutics for cancer

  Tathagata Dutta

  PDF HTML

• Pharmacokinetics, metabolism and tissue distribution of norcantharidin in human body, studied by HPLC-MS/MS and isotope-labeled methods

  Rui-chen Guo, Chun-min Wei, Rui Zhang, Ben-jie Wang, Gui-yan Yuan

  PDF HTML

• Quantitative structure-activity relationship studies on anti-hepatitis viral agents

  S.P.Gupta, Vaishali M.Patil, Preet K.Arora

  PDF HTML

• TargetED therapy for treatment of lung cancer

  Dr. Mandip Singh Sachdeva

  PDF HTML

• Hopeful Trip from Herbs to Humans

  Harish C. Joshi

  PDF HTML

• Minimal effective concentration and efficacy of epoetins

  Wojciech Krzyzanski

  HTML

• Biophotonics: Application towards Modern Drug Discovery

  Srinivas Kantevari

  PDF HTML

• Molecular drug targets for development of antidepressant drugs

  Dinesh Dhingra

  PDF HTML

• Stability and rat skin permeation of vitamin E and vitamin E acetate in cosmetic preparations

  Aly Nada, Y.S.R. Krishnaiah, Abdel-Azim Zaghloul, Ibrahim Khattab

  PDF HTML

• Enhancing oral bioavailability of drugs using self-emulsifying drug delivery systems

  Dr Bhupinder Singh Bhoop

  PDF HTML

• Pharmacokinetic significance of diabetes-induced changes in CYP3A activity

  Dr. S.N. Umathe

  PDF HTML

• MORE THAN A CO-RECEPTOR: NEW PERSPECTIVES OF NEUROPILIN-1 FUNCTION IN ENDOTHELIUM AND TUMOR CELLS

  Debabrata (Dev) Mukhopadhyay

  PDF HTML

• Local antibiotic delivery systems for the treatment of Osteomyelitis. The use of fibrin clot as a carrier. An in vitro and in vivo pharmacokinetic study

  Stefanos Tsourvakas

  PDF HTML

• Pharmacokinetic study of hair dye poisoning: A study of 50 cases

  M. Nagulu, S. Srinivas, S. Vijaya kumar, K. Swetha, P. Sabthi

  PDF HTML

• Is natural product domain a good hunting hub in the navigation of drug like and drug molecules?

  A. Jayashree, Preethi Badrinarayan, M. Anji Reddy, G. Narahari Sastry

  PDF HTML

• Therapeutic alternatives from venoms and toxins: Drug challenges of the future

  Shivaji P.Gawade

  HTML

• Human Membrane Guanylate Cyclases: Understanding the Structural Basis of Receptor-Ligand Interactions and Approaches to Drug Design

  Dr. Paul Roesch

  PDF HTML

• Liver diseases affecting bioavailability

  Dibya Sundar Panda

  PDF HTML

• Pros and cons of ocular bio-availability of drugs

  Dr. T.Velpandian

  PDF HTML

• Are bioavailability studies warranted in specific disease states?

  S.B. Bhise

  PDF HTML

• Immunomodulation by biologic Intravenous immunoglobulins IVIG: immune thrombocytopenia ITP as a model for the last 30 Years

  Paul Imbach

  PDF HTML

• The bioavailability of heparin-binding molecules on vascular walls is regulated by heparan sulfate and flow rate

  Michael Fannon

  PDF HTML

• Factors affecting bioavailability and bioequivalence

  J. Vijaya Ratna

  PDF HTML

• Combining populationbased mechanistic modelling of oral absorption and parameter estimation algorithms to obtain reliable predictions of bioavailability

  Sebastian Polak

  PDF HTML

• Aspirin resistance: the role of poor bioavailability of enteric coated aspirin

  Dermot Cox

  PDF HTML

• Enhancing drug bioavailability by overcoming intestinal metabolism

  Basavaraj K. Nanjwade

  HTML

• Enhancement of Bioavailability of Aceclofenac using Solid Dispersion Technique

  Dua Kamal, Sara U.V.S, D.K. Agrawal, Sharma V.K. Pabreja K.

  PDF HTML

• Assessing BA/BE of topical formulations in vitro: in vitro - in vivo correlation provides a practical surrogate to clinical BE studies

  Sam Raney

  PDF HTML

• Understanding the significance of in-vitro/ in-vivo correlation in pharmacokinetic predictions

  Dr. Shivanand P. Puthli

  PDF HTML

• In vitro methods to determine bioavailability & IVIVC of oral dosage forms and drug delivery systems

  Vijay D. Wagh

  PDF HTML

• Effect of test parameters on in-vitro method to determine bioavailability of dosage forms

  Abhishek Kumar Jain

  PDF HTML

• Endeavoring Biowaivers using IVIVC: shifting paradigms

  Prof. Bhupinder Singh Bhoop

  PDF HTML

• Transdermal bioavailability of trazodone hydrochloride: invitro-invivo correlation

  Malay K. Das

  PDF HTML

• PHARMACEUTICAL COCRYSTALS TO MODIFY PHYSICO-CHEMICAL AND DISSOLUTION PROFILE OF APIS

  Prof. Ashwini Nangia

  PDF HTML

• SYNTHESIS OF NOVEL HETEROCYCLIC COMPOUNDS FOR INDUCTION OF APOPTOSIS IN HUMAN LEUKEMIA CELLS

  Kanchugarakoppal S. Rangappa

  HTML

• CHALLENGES IN THE DESIGN OF COMPARATIVE BIOAVAILABILITY STUDIES - AN INDUSTRY PERSPECTIVE

  Dr. Siddarth Chachad

  PDF HTML

• BIOEQUIVALENCE STRATEGIES FOR ONCOLOGY PRODUCTS

  Dr. Shivprakash Rathnam

  PDF HTML

• BIOAVAILABILITY AND BIOEQUIVALENCE STUDIES OF CITRIC ACID AND MALONIC ACID BASED ASPIRIN EFFERVESCENT TABLETS

  Dr. Sanjita Das, Anju Gauniya, Dr. Subrat Mallick

  PDF HTML